"Ospedale Civile di Mirano"
Welcome,         Profile    Billing    Logout  
 1 Trial 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Azzarello, Giuseppe
LIBImAb, NCT04776655: Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB

Checkmark Phase III study to compare bevacizumab or cetuximab plus FOLFIRI in patients with advanced colorectal cancer RAS/BRAF wild type (wt) on tumor tissue and RAS mutated (mut) in liquid biopsy: LIBImAb Study.
Recruiting
3
280
Europe
Bevacizumab, Avastin, Cetuximab, Erbitux, 5-FU, 5 Fluorouracil, Irinotecan, Irinotecano, Calcium levofolinate, Levofolinic acid
Azienda Unità Sanitaria Locale Reggio Emilia, Istituto Di Ricerche Farmacologiche Mario Negri, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
Colorectal Cancer, Metastatic Colorectal Cancer, RAS Mutation
04/23
04/24

Download Options